Article

Pharmacologic management in cerebral palsy may be directed to spasticity, dystonia, or a combination of these after an assessment of treatment goals. The most common pharmacologic agents are botulinum toxin (discussed elsewhere) for spasticity and dystonia, baclofen, diazepam, dantrolene sodium, and tizanidine for spasticity, and L-Dopa and benzhexol for dystonia. Medications are introduced slowly to monitor efficacy and side effects and are performed largely on an open trial basis, as evidence of specific treatment programs is lacking.

Langue : ANGLAIS

Identifiant basis : 2004229040